Impact of Aurora kinase A and B expression on response to neoadjuvant chemotherapy and patient outcome in muscle-invasive bladder cancer (MIBC).

被引：1
|
作者：
Burgess, Earle Frederick [1 ]
Livasy, Chad [1 ]
Trufan, Sally J. [1 ]
Hartman, Aaron [1 ]
Guerrieri, Renato [1 ]
Naso, Caroline [1 ]
Clark, Peter E. [1 ]
Grigg, Claud [1 ]
Symanowski, James Thomas [1 ]
Raghavan, Derek [1 ]
机构：
[1] Atrium Hlth, Levine Canc Inst, Charlotte, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 07期
关键词：
D O I：
10.1200/JCO.2019.37.7_suppl.393
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
393
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Association of Medicaid expansion with racial disparities in timely neoadjuvant chemotherapy (NAC) in muscle-invasive bladder cancer (MIBC).
    Jiang, Changchuan
    Perimbeti, Stuthi
    Deng, Lei
    Jatwani, Karan
    Roy, Arya
    Chatta, Gurkamal S.
    George, Saby
    Gopalakrishnan, Dharmesh
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [32] Determinants of neoadjuvant chemotherapy use in muscle-invasive bladder cancer
    Carvalho, Filipe L. F.
    Zeymo, Alexander
    Egan, Jillian
    Kelly, Colleen H.
    Zheng, Chaoyi
    Lynch, John H.
    Hwang, Jonathan
    Stamatakis, Lambros
    Krasnow, Ross E.
    Kowalczyk, Keith J.
    [J]. INVESTIGATIVE AND CLINICAL UROLOGY, 2020, 61 (04) : 390 - 396
  • [33] Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
    Seiler, Roland
    Ashab, Hussam Al Deen
    Erho, Nicholas
    van Rhijn, Bas W. G.
    Winters, Brian
    Douglas, James
    Van Kessel, Kim E.
    van de Putte, Elisabeth E. Fransen
    Sommerlad, Matthew
    Wang, Natalie Q.
    Choeurng, Voleak
    Gibb, Ewan A.
    Palmer-Aronsten, Beatrix
    Lam, Lucia L.
    Buerki, Christine
    Davicioni, Elai
    Sjodahl, Gottfrid
    Kardos, Jordan
    Hoadley, Katherine A.
    Lerner, Seth P.
    McConkey, David J.
    Choi, Woonyoung
    Kim, William Y.
    Kiss, Bernhard
    Thalmann, George N.
    Todenhofer, Tilman
    Crabb, Simon J.
    North, Scott
    Zwarthoff, Ellen C.
    Boormans, Joost L.
    Wright, Jonathan
    Dall'Era, Marc
    van der Heijden, Michiel S.
    Black, Peter C.
    [J]. EUROPEAN UROLOGY, 2017, 72 (04) : 544 - 554
  • [34] The neoadjuvant management of muscle-invasive bladder cancer (MIBC) in Canada: A national survey of urologists
    Sridhar, Srikala S.
    Chi, Kim N.
    North, Scott A.
    Black, Peter C.
    Wood, Lori
    Hsu, Tina
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [35] The impact of pathologic response to neoadjuvant chemotherapy on conditional survival among patients with muscle-invasive bladder cancer
    Waingankar, Nikhil
    Jia, Rachel
    Marqueen, Kathryn E.
    Audenet, Francois
    Sfakianos, John P.
    Mehrazin, Reza
    Ferket, Bart S.
    Mazumdar, Madhu
    Galsky, Matthew D.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (09) : 572.e21 - 572.e28
  • [36] Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
    Zargar, Homayoun
    Espiritu, Patrick N.
    Fairey, Adrian S.
    Mertens, Laura S.
    Dinney, Colin P.
    Mir, Maria C.
    Krabbe, Laura-Maria
    Cookson, Michael S.
    Jacobsen, Niels-Erik
    Gandhi, Nilay M.
    Griffin, Joshua
    Montgomery, Jeffrey S.
    Vasdev, Nikhil
    Yu, Evan Y.
    Youssef, David
    Xylinas, Evanguelos
    Campain, Nicholas J.
    Kassouf, Wassim
    Dall'Era, Marc A.
    Seah, Jo-An
    Ercole, Cesar E.
    Horenblas, Simon
    Sridhar, Srikala S.
    McGrath, John S.
    Aning, Jonathan
    Shariat, Shahrokh F.
    Wright, Jonathan L.
    Thorpe, Andrew C.
    Morgan, Todd M.
    Holzbeierlein, Jeff M.
    Bivalacqua, Trinity J.
    North, Scott
    Barocas, Daniel A.
    Lotan, Yair
    Garcia, Jorge A.
    Stephenson, Andrew J.
    Shah, Jay B.
    van Rhijn, Bas W.
    Daneshmand, Siamak
    Spiess, Philippe E.
    Black, Peter C.
    [J]. EUROPEAN UROLOGY, 2015, 67 (02) : 241 - 249
  • [37] Comparison of Neoadjuvant and Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer
    Macleod, Liam C.
    Fam, Mina M.
    Yabes, Jonathan G.
    Hale, Nathan E.
    Turner, Robert M., II
    Lopa, Samia H.
    Gingrich, Jeffrey R.
    Borza, Tudor
    Skolarus, Ted A.
    Davies, Benjamin J.
    Jacobs, Bruce L.
    [J]. CLINICAL GENITOURINARY CANCER, 2020, 18 (03) : 201 - +
  • [38] Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
    Vasdev, N.
    Zargar, H.
    Fairey, A.
    Espiritu, P.
    Krabbe, L.
    Mongomery, J.
    Gandhi, N.
    Griffin, J.
    Yu, E.
    Campain, N.
    Xylinas, E.
    Horenblas, S.
    Yousef, D.
    Kassouf, W.
    Shariat, S.
    Aning, J.
    Wright, J.
    Holzbeierlein, J.
    Bivalacqua, T.
    Morgan, T.
    North, S.
    Borcas, D.
    Lotan, Y.
    Shah, J.
    Spiess, P.
    Van Rhijn, B.
    Daneshmand, S.
    Black, P.
    Thorpe, A. C.
    [J]. BJU INTERNATIONAL, 2014, 113 : 25 - 25
  • [39] Neoadjuvant versus adjuvant chemotherapy for muscle-invasive bladder cancer
    Clark, Peter E.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (06) : 821 - 830
  • [40] Retrospective study of treatment and outcome for muscle-invasive bladder cancer (MIBC) in Kentucky
    Williams, Justin Allen
    Huang, Bin
    Chen, Quan
    Wang, Peng
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345